Login
value-dx
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2023
    • WAAW Campaign 2022
    • WAAW Campaign 2021
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Events
    • Interviews
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2023
    • WAAW Campaign 2022
    • WAAW Campaign 2021
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Events
    • Interviews
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform
VALIDATING DIAGNOSTICS
TO COMBAT ANTIMICROBIAL RESISTANCE BY
OPTIMISING ANTIBIOTIC USE

NEWS

A new home for VALUE-Dx resources at ERS’s e-learning hub

Concluding Interview with project lead Em. Prof. Herman Goossens

Developing a Clinical Algorithm to support Etiological Diagnosis of CARTIs

View more

CONSORTIUM PARTNERS

Janssen
Uoxf
UA web
GÖG Web
Accelerate Web
BD Web
UNIVR web
ERS Web
penta_centred-col
RAMBAM Web
FIND Web
Groningen Web
ESCMID Web
NICE Web
Berry Consultants Web
BU Web
Abbott Web
ZonMw_Web
IBBL Web
Artboard 1
UMCU-logo
Universidad de la Rioja
UoE_Centred Logo_CMYK_v1_160215
ERS
View more

SUBSCRIBE TO OUR NEWSLETTER

Social Media

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.

Copyright - Value-Dx - Any dissemination of results must indicate that it reflects only the author's view and that the JUis not responsible for any use that may be made of the information it contains.
Scroll to top Scroll to top Scroll to top
We use cookies to ensure that we can give you the best experience on our website. AcceptRefuseRead More